Dear Colleagues:
Happy New Year! Below is a summary of recent NIH Guide Notices. Please review the notices and forward it to faculty, researchers, and staff, as appropriate. Questions regarding the notices should be directed to your Federal Contract and Grant Officer.
(NOT-OD-25-059)
In April 2024, the Office of Management and Budget issued revisions to the Uniform Administrative Requirements for Federal Financial Assistance, located at 2 CFR Part 200. On October 2, 2024, HHS issued an Interim Final Rule that provides the HHS implementation of the 2024 Revisions.
With the issuance of this notice, NIH implements the OMB administrative flexibilities and updates our grant terms and conditions related to administrative requirements that are outlined throughout 2 CFR Part 200. NIH will incorporate the policy updates outlined in this notice in the FY25 issuance of the NIH Grants Policy Statement.
(NOT-OD-25-047)
On August 25, 2022, the White House Office of Science and Technology Policy (OSTP) released updated policy guidance (2022 OSTP Memorandum) to all federal agencies with research and development expenditures to further promote equity, advance trust in science, and continue to advance American scientific leadership. Following the 2022 OSTP Memorandum, NIH released its Plan to Enhance Public Access to the Results of NIH-Supported Research in February 2023 (hereafter, the NIH Public Access Plan) and its Draft Public Access Policy in June 2024. The NIH Public Access Plan and Draft Public Access Policy provided a roadmap for how NIH proposed to accelerate access to scholarly publications, consistent with the government-wide expectation to remove the 12-month embargo period before public availability. This 2024 NIH Public Access Policy is consistent with the expectations of the 2022 OSTP Memorandum regarding scholarly publications and is informed by all public feedback, including comments submitted in response to the NIH Draft Public Access Policy.
(NOT-OD-25-048)
This Guidance clarifies publication costs that are not allowable based on existing cost principles. It also outlines Points to Consider for Authors and Institutions in Assessing Reasonable Costs. This Guidance is intended to help funded authors and institutions understand what costs are allowable and reasonable under the NIH Public Access Policy. The NIH GPS also permits allowable and reasonable costs to be used to make public other works resulting from NIH funding that are not subject to the NIH Public Access Policy. This Guidance includes a brief section describing these kinds of works. The factors for what make costs unallowable are broadly applicable, regardless of whether the publication or other work is subject to the NIH Public Access Policy.
(NOT-OD-25-049)
This Guidance assists authors in navigating compliance with the NIH Public Access Policy with minimal burden. NIH also encourages authors to be clear with journals and publishers to ensure journals and publishers understand that NIH has a right to make Author Accepted Manuscripts publicly available upon the Official Date of Publication.
(NOT-OD-25-054)
The Department of Health and Human Services (HHS), including National Institutes of Health (NIH), operates under the American Relief Act, 2025 (Public Law 118-84) signed by President Biden on December 21, 2024. This Act (CR) continues government operations through March 14, 2025, at the Fiscal Year (FY) 2024 enacted level, with no reduction.
(NOT-OD-25-061)
The purpose of this Notice is to provide researchers and research institutions funded by National Institutes of Health (NIH) grants and cooperative agreements with information pertaining to NIH’s implementation of the U.S. Government Policy for Oversight of Dual Use Research of Concern and Pathogens with Enhanced Pandemic Potential (herein referred to as the DURC/PEPP Policy).
NIH intends to implement the DURC/PEPP Policy effective May 6, 2025. NIH will provide additional details and requirements, including applicable grant and cooperative agreement activity codes, specific implementation timelines, and information regarding implementation for other NIH funding mechanisms, (e.g., contracts, Other Transactions), in future Guide Notices.
(NOT-HS-25-010)
On February 22, 2013, the White House Office of Science and Technology Policy (OSTP) released a memorandum entitled “Increasing Access to the Results of Federally Funded Scientific Research.” This memorandum requires federal agencies to make the results of federally funded scientific research available to and useful for the public, industry, and the scientific community. In response, AHRQ published a plan for establishing a policy for public access to scientific publications and scientific data resulting from AHRQ funding (https://www.ahrq.gov/funding/policies/publicaccess/index.html), the Policy for Public Access to AHRQ Funded Scientific Publications (NOT-HS-16-008), and the Data Management Plan Policy (NOT-HS-20-011).
(NOT-HS-25-011)
On August 25, 2022, the OSTP released updated policy guidance (2022 OSTP Memo) to further promote equity and advance trust in science. In 2023 AHRQ published a Request for Information seeking public comments on proposed updates to its public access plan for peer reviewed scholarly publications and scientific data resulting from AHRQ funding. AHRQ updated its Plan for Establishing a Policy for Public Access to Scientific Publications and Scientific Data in Digital Format Resulting from AHRQ Funding (Plan). AHRQ is now updating its Public Access Policy for Scientific Publications. The updates are intended to accelerate access to scholarly publications, consistent with the expectation to remove the currently allowable 12-month embargo period before public availability.
Thank you,
Jeff Warner
Senior Director, Sponsored Projects Administration
Office of Research
University of California Irvine
949-824-7654